Short-Chain fatty acids suppress lipopolysaccharide-Induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-?B Pathway in RAW264.7 cells

Inflammation

Volumn 35, Issue 5, 2012, Pages 1676-1684

  Liu, Tengfei ^a   Li, Jing ^a   Liu, Yuxin ^a   Xiao, Nan ^a   Suo, Haitao ^a   Xie, Kun ^a   Yang, Chunliu ^a   Wu, Chen ^a  

^a HEBEI UNIVERSITY   (China)

Author keywords

Inducible nitric synthase; LPS; NF kB p65; Proinflammatory factors; SCFAs

Indexed keywords

ACETIC ACID; BUTYRIC ACID; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROPIONATE SODIUM; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STRAIN RAW264.7; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; MOUSE; NONHUMAN;

ANIMALS; BUTYRATES; CELL LINE; FATTY ACIDS, VOLATILE; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROPIONATES; SODIUM ACETATE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 84866740088     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9484-z     Document Type: Article

References (38)

1. Duffield, J.S. 2003. The inflammatory macrophage: A story of Jekyll and Hyde. Clinical Science 104: 27-38.
2. Sergij Goerdt, O.P., K. Schledzewski, R. Birk, A. Gratchev, P. Guillot, N. Hakiy, C.-D. Klemke, E. Dippel, V. Kodelja, and C.E. Orfanos. 1999. Alternative versus classical activation of macrophages. Pathobiology 67: 5-6.
3. Cook, S.I., and J.H. Sellin. 1998. Review article: Short chain fatty acids in health and disease. Alimentary Pharmacology & Therapeutics 12(6): 499-507.
4. Harig, J.M., K.H. Soergel, R.A. Komorowski, and C.M. Wood. 1989. Treatment of diversion colitis with short-chain-fatty acid irrigation. The New England Journal of Medicine 320: 23-28.
5. Scheppach, W., P. Bartram, A. Richter, F. Richter, H. Liepold, G. Dusel, G. Hofstetter, J. Rüthlein, and H. Kasper. 1992. Effect of short-chain fatty acids on the human colonic mucosa in vitro. Journal of Parenteral and Enteral Nutrition 16: 43.
6. Wong, J.M., R. de Souza, C.W. Kendall, A. Emam, and D.J. Jenkins. 2006. Colonic health: Fermentation and short chain fatty acids. Journal of Clinical Gastroenterology 40: 235-243.
7. Hijova, E., and A. Chmelarova. 2007. Short chain fatty acids and colonic health. Bratislavske Lekarske Listy 108: 354-358.
8. Miller, S.J. 2004. Cellular and physiological effects of short-chain fatty acids. Mini Reviews in Medicinal Chemistry 4: 839-845.
9. Meijer, K., P. de Vos, and M.G. Priebe. 2010. Butyrate and other short-chain fatty acids as modulators of immunity: What relevance for health? Current Opinion in Clinical Nutrition and Metabolic Care 13: 715-721.
10. Mohana Kumar, B., H.J. Song, S.K. Cho, S. Balasubramanian, S.Y. Choe, and G.J. Rho. 2007. Effect of histone acetylation modification with sodium butyrate, a histone deacetylase inhibitor, on cell cycle, apoptosis, ploidy and gene expression in porcine fetal fibroblasts. The Journal of Reproduction and Development 53: 903-913.
11. Ni, Y.F., J. Wang, X.L. Yan, F. Tian, J.B. Zhao, Y.J. Wang, and T. Jiang. 2010. Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide- induced acute lung injury in mice. Respiratory Research 11: 33.
12. Usami, M., K. Kishimoto, A. Ohata, M. Miyoshi, M. Aoyama, Y. Fueda, and J. Kotani. 2008. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutrition Research (New York, N.Y) 28: 321-328.
13. Kawamura, T., A. Andoh, A. Nishida, M. Shioya, Y. Yagi, T. Nishimura, T. Hashimoto, T. Tsujikawa, H. Yasui, and Y. Fujiyama. 2009. Inhibitory effects of short-chain fatty acids on matrix metalloproteinase secretion from human colonic subepithelial myofibroblasts. Digestive Diseases and Sciences 54: 238-245.
14. Cavaglieri, C.R., A. Nishiyama, L.C. Fernandes, R. Curi, E.A. Miles, and P.C. Calder. 2003. Differential effects of short-chain fatty acids on proliferation and production of pro-and antiinflammatory cytokines by cultured lymphocytes. Life Sciences 73: 1683-1690.
15. Park, J.S., E.J. Lee, J.C. Lee, W.K. Kim, and H.S. Kim. 2007. Anti-inflammatory effects of short chain fatty acids in IFN-[gamma]-stimulated RAW 264.7 murine macrophage cells: Involvement of NF-[kappa] B and ERK signaling pathways. International Immunopharmacology 7: 70-77.
16. Cox, M.A., J. Jackson, M. Stanton, A. Rojas-Triana, L. Bober, M. Laverty, X. Yang, F. Zhu, J. Liu, and S. Wang. 2009. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E2 and cytokines. World Journal of Gastroenterology: WJG 15: 5549-5557.
17. Vinolo, M.A.R., H.G. Rodrigues, E. Hatanaka, F.T. Sato, S.C. Sampaio, and R. Curi. 2010. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. The Journal of Nutritional Biochemistry 22: 849-855.
18. Hamer, H.M., D.M.A.E. Jonkers, G.M. Stein, M.W. Schmolz, F.J. Troost, A. Bast, K. Venema, and R.J.M. Brummer. 2009. C3-C6 but not C2 short chain fatty acids affect cytokine release in a co-culture system of Caco-2 cells and whole blood. In Short chain fatty acids and colonic health. Maastricht University. 49-69.
19. Tedelind, S., F. Westberg, M. Kjerrulf, and A. Vidal. 2007. Antiinflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease. World Journal of Gastroenterology 13: 2826.
20. Li, J., N. Xiao, J. Zhang, S. Cui, and Y. Liu. 2011. Protective effect of sodium acetate against endotoxic shock by Dgalactosamine and lipopolysaccharide. Jiangsu Medical Journal 37: 517-519.
21. Cummings, J.H., E.W. Pomare, W.J. Branch, C.P. Naylor, and G.T. Macfarlane. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28: 1221-1227.
22. McOrist, A.L., G.C.J. Abell, C. Cooke, and K. Nyland. 2008. Bacterial population dynamics and faecal short-chain fatty acid (SCFA) concentrations in healthy humans. British Journal of Nutrition 100: 138-146.
23. Scheppach, W.M., C.E. Fabian, and H.W. Kasper. 1987. Fecal short-chain fatty acid (SCFA) analysis by capillary gas-liquid chromatography. The American Journal of Clinical Nutrition 46: 641-646.
24. Vinolo, M.A.R., H.G. Rodrigues, E. Hatanaka, C.B. Hebeda, S.H.P. Farsky, and R. Curi. 2009. Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites. Clinical Science 117: 331-338.
25. Mirmonsef, P., M.R. Zariffard, D. Gilbert, H. Makinde, A.L. Landay, and G.T. Spear. 2012. Short-chain fatty acids induce proinflammatory cytokine production alone and in combination with Toll-like receptor ligands. American Journal of Reproductive Immunology 67(5): 391-400. doi:10.1111/j.600-0897.2011. 01089.x.
26. Macia, L., A.N. Thorburn, L.C. Binge, E. Marino, K.E. Rogers, K.M. Maslowski, et al. 2012. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunological Reviews 245: 164-176.
27. Garland, S.H. 2011. Short chain fatty acids may elicit an innate immune response from preadipocytes: A potential link between bacterial infection and inflammatory diseases. Medical Hypotheses 76: 881-883.
28. Vinolo, M.A.R., E. Hatanaka, R.H. Lambertucci, P. Newsholme, and R. Curi. 2009. Effects of short chain fatty acids on effector mechanisms of neutrophils. Cell Biochemistry and Function 27: 48-55.
29. Mosser, D.M., and J.P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nature Reviews 8: 958-969.
30. Kim, E.Y., and K.D. Moudgil. 2008. Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunology Letters 120: 1-5.
31. Yoon, W.J., Y.M. Ham, B.S. Yoo, J.Y. Moon, J. Koh, and C.G. Hyun. 2009. Oenothera laciniata inhibits lipopolysaccharide induced production of nitric oxide, prostaglandin E2, and proinflammatory cytokines in RAW264.7 macrophages. Journal of Bioscience and Bioengineering 107: 429-438.
32. Moncada, S., R.M.J. Palmer, and E.A. Higgs. 1991. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43(2): 109-142.
33. MacMicking, J., Q.W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annual Review of Immunology 15: 323-350.
34. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. The FASEB Journal 6(12): 3051-3064.
35. Detmers, P.A., M. Hernandez, J. Mudgett, H. Hassing, C. Burton, and S. Mundt. 2000. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. The Journal of Immunology 165(6): 3430-3435.
36. Petros, A., D. Bennett, and P. Vallance. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. The Lancet 338: 1557-1558.
37. Cavaillon, J.M. 1994. Cytokines and macrophages. Biomedicine and Pharmacotherapy = Biomedecine and Pharmacotherapie 48: 445-453.
38. Brown, A.J., S.M. Goldsworthy, A.A. Barnes, M.M. Eilert, L. Tcheang, D. Daniels, A.I. Muir, M.J. Wigglesworth, I. Kinghorn, N.J. Fraser, N.B. Pike, J.C. Strum, K.M. Steplewski, P.R. Murdock, J.C. Holder, F.H. Marshall, P.G. Szekeres, S. Wilson, D.M. Ignar, S.M. Foord, A. Wise, and S.J. Dowell. 2003. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. The Journal of Biological Chemistry 278: 11312-11319.